期刊文献+

地氯雷他定对过敏性哮喘豚鼠模型肺泡灌洗液IL-4和IL-13水平的影响 被引量:3

Effects of desloratadine on the levels of IL-4 and IL-13 in bronchoalveolar lavage fluid of allergic asthmatic rats model
下载PDF
导出
摘要 目的研究地氯雷他定对过敏性哮喘豚鼠模型肺泡灌洗液IL-4和IL-13水平的影响。方法用卵蛋白造成过敏性哮喘豚鼠模型,观察地氯雷他定对过敏性哮喘豚鼠哮喘潜伏期、肺泡灌洗液IL-4和IL-13水平的影响。结果地氯雷他定能显著延长过敏性哮喘豚鼠哮喘潜伏期,明显降低肺泡灌洗液IL-4和IL-13水平。结论地氯雷他定能通过降低细胞因子IL-4和IL-13水平来延缓哮喘的发作,为其临床治疗哮喘提供实验依据。 Objective 5BTo study the effects of desloratadine on the level of IL-4 and IL-13 in bronchoalveolar lavage fluid of allergic asthmatic rat model. Methods The allergic asthmatic rat model was induced by ovalbumin. Then the effects of desloratadine on the latent period of asthma,the level of IL-4 and IL-13 in bronchoalveolar lavage fluid were observed. Results Desloratadine could extend the latent period of asthma,and decrease the level of IL-4 and IL-13 in bronchoalveolar lavage fluid. Conclusion Desloratadine could delay the onset of asthma by decreasing the level of IL-4 and IL-13. So it provides basis for the clinical use in treating asthma.
出处 《实用临床医药杂志》 CAS 2014年第16期105-106,111,共3页 Journal of Clinical Medicine in Practice
关键词 地氯雷他定 过敏性哮喘 豚鼠 肺泡灌洗液 IL-4 IL-13 desloratadine allergic asthma rats bronchoalveolar lavage fluid IL-4 IL-13
  • 相关文献

参考文献2

二级参考文献45

  • 1吴林峰,毛荣彪,孙祖良.支气管哮喘患者血清可溶性E-选择素含量的变化及意义[J].中国全科医学,2005,8(21):1756-1757. 被引量:6
  • 2Juhlin L. Inhibition of cold urticaria by desloratadine[ J]. J Dermatol Treat, 2004,15( 1 ) :51 - 59,.
  • 3Ten Eick AP, Blumer JL, Reed MD. Safety of antihistamines in children[J]. Drug Saf, 2001,24(2) : 119 - 147.
  • 4Anthes JC, Richard C, West RE, et al. Functional characterization of desloratadine and other antihistamines in humane H1 receptors [J].Allergy, 2000,55 ( Suppl 63 ) : S279.
  • 5Lippert U, Moiler A, welker P, et al. Inhibition of cytokine secretion from human leukemic mast cells and basophilis by H1 and H2 receptor antagonists[J]. Exp Dermatol,2000,9(2) : 118 - 124.
  • 6Bloom M, Staudinger H, Herron J. Safety of desloratadine syrup in children[J]. Curr Med Res Opin ,2004,20(12) : 1959 - 1965.
  • 7Banfield C,Gupta S, Marino M, et al. Grapefruit juice reduces the oral bioavailability of fexofenadine but not desloratadine [ J]. Clin Pharmacokinet, 2002,41 (4) : 311 - 318.
  • 8Bachert C. Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis [ J ]. Allergy, 2001,56 ( Suppl 65 ) : S14 - S20.
  • 9Ring J,Hein R, Gauger A, et al. Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria:a randomized,douhle-blind, placebo-controlled study [ J]. lnt J Dermatol, 2001,40(1):72-76.
  • 10Tagllalatela M, Castaldo P, Pannaccione A, et al. Cardiac ion channels and antihistamines: possible mechanisms of cadiotoxicity[J].Clin Exp Allergy, 1999,29( Suppl 3):S182- S189.

共引文献67

同被引文献36

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部